Lataa...
Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent
PARP inhibitors (PARPi) are potentially effective therapeutic agents capable of inducing synthetic lethality in tumors with deficiencies in homologous recombination (HR)-mediated DNA repair such as those carrying BRCA1 mutations. However, BRCA mutations are rare, the majority of tumors are proficien...
Tallennettuna:
| Julkaisussa: | Mol Cancer Res |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6713455/ https://ncbi.nlm.nih.gov/pubmed/29592899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-18-0106 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|